Vytorin Lawsuits for Rhabdomyolysis, Heart Attack, and Stroke

October 11, 2013

Important Information

Attorneys working with ClassAction.org are no longer reviewing claims for this case. The information here is for reference only. A list of open investigations can be viewed here.

Comments |

At A Glance

This Alert Affects
Vytorin users who have developed rhabdomyolysis, cancer, or liver disease, or who have suffered a heart attack or stroke.
Damages
Reportedly, users taking this drug have an increased risk of developing rhabdomyolysis and liver disease. The drug also reportedly increases the risk of heart attack, stroke, and cancer.
Company(ies)
Merck
Additional Details
Vytorin users who have developed rhabdomyolysis, cancer, or liver disease, or who have suffered a heart attack or stroke.
Date
Although the drug has reportedly been linked to increased health risks, a Vytorin recall has not yet been issued.